Carmat SAS (ALCAR):企業の財務・戦略的SWOT分析

◆英語タイトル:Carmat SAS (ALCAR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME41415FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carmat SAS (Carmat) is a medical equipment company that provides artificial organs. The company provides development of innovative artificial organs, artificial heart and other vital organs, among others. Carmat artificial heart products consist of an implantable heart. The company offers components which help connect to an electric power supply; and external systems such as a power supply, monitoring and hospital control system for the post-operative period. Carmat provides services such as wearable power supply and communication system, besides a remote diagnosis system. The company product serve heart failure patients in the US and European countries. Carmat is headquartered in Paris, France.

Carmat SAS Key Recent Developments

Feb 01,2021: CARMAT appoints Prof. Christian Latrémouille as Director of Surgical Affairs
Nov 02,2020: CARMAT obtains non-dilutive financing of €10 million guaranteed by the French state
Sep 09,2020: CARMAT publishes its 2020 half-year results and provides an update on its activities and outlook
May 13,2020: CARMAT obtains approval for the reimbursement of its total artificial heart during the US clinical feasibility study
Feb 12,2020: CARMAT reports its 2019 annual results and confirms its 2020 objectives

This comprehensive SWOT profile of Carmat SAS provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Carmat SAS including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Carmat SAS – Key Information
Carmat SAS – Overview
Carmat SAS – Key Employees
Carmat SAS – Key Employee Biographies
Carmat SAS – Key Operational Heads
Carmat SAS – Major Products and Services
Carmat SAS – History
Carmat SAS – Company Statement
Carmat SAS – Locations And Subsidiaries
Carmat SAS
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Carmat SAS – Business Description
Carmat SAS – Corporate Strategy
Carmat SAS – SWOT Analysis
SWOT Analysis – Overview
Carmat SAS – Strengths
Carmat SAS – Weaknesses
Carmat SAS – Opportunities
Carmat SAS – Threats
Carmat SAS – Key Competitors

Section 3 – Company Financial Performance Charts

Carmat SAS – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Carmat SAS, Key Information
Carmat SAS, Key Ratios
Carmat SAS, Share Data
Carmat SAS, Major Products and Services
Carmat SAS, History
Carmat SAS, Key Employees
Carmat SAS, Key Employee Biographies
Carmat SAS, Key Operational Heads
Carmat SAS, Other Locations
Carmat SAS, Subsidiaries
Carmat SAS, Key Competitors
Carmat SAS, SWOT Analysis
Carmat SAS, Ratios based on current share price
Carmat SAS, Annual Ratios
Carmat SAS, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Carmat SAS (ALCAR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Infant Bacterial Therapeutics AB (IBT B)-製薬・医療分野:企業M&A・提携分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops prophylactic therapies for the medical needs of the premature infant. The company develops pharmaceutical drug candidates for gastrointestinal neonatal condition that causes mucosal i …
  • Vitro, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Vitro, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ITT Inc.:企業の戦略・SWOT・財務分析
    ITT Inc. - Strategy, SWOT and Corporate Finance Report Summary ITT Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Alteogen Inc (196170):製薬・医療:M&Aディール及び事業提携情報
    Summary Alteogen Inc (Alteogen) is a biotech company that develops proprietary antibody-drug conjugate and antibody biosimilars. The company’s pipeline products include ALT-P1, ALT-Q2, ALT-P7, ALT-Q5, ALT-L9 and ALT-L2. Its products are used for long-acting human growth hormone, long-acting factor V …
  • Mitsubishi Motors Corporation (7211):企業の財務・戦略的SWOT分析
    Mitsubishi Motors Corporation (7211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SpectraCure AB (SPEC)-製薬・医療分野:企業M&A・提携分析
    Summary SpectraCure AB (SpectraCure) is a healthcare technology company that develops different methods for treatment planning and laser light dose management for cancer treatment. The company develops and therapy system (PDT) commercializes photodynamic with IDOSE for tumors. Its IDOSE platform all …
  • Coesia S.p.A.:戦略・SWOT・企業財務分析
    Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Coesia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Shangri-La Asia Ltd:戦略・SWOT・企業財務分析
    Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Offshore Oil Engineering Co Ltd (600583):石油・ガス:M&Aディール及び事業提携情報
    Summary Offshore Oil Engineering Co Ltd (COOEC), a subsidiary of China National Offshore Oil Corp, is a general engineering contractor that offers offshore engineering construction services. The company’s services include engineering, procurement, construction, installation, maintenance and underwat …
  • Cipla Ltd (CIPLA):企業の財務・戦略的SWOT分析
    Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mgm China Holdings Ltd:企業の戦略・SWOT・財務分析
    Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Mgm China Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ABPA Holdings Limited:企業の戦略的SWOT分析
    ABPA Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Gordon Food Service Inc:企業の戦略的SWOT分析
    Gordon Food Service Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Omega Pharma NV-製薬・医療分野:企業M&A・提携分析
    Summary Omega Pharma NV (Omega Pharma), a subsidiary of Perrigo Company plc, is a pharmaceutical company focusing on the development, manufacture and sale of prescription-free or Over the Counter (OTC) health and personal care products. The company's product portfolio includes cough and cold product …
  • La-Z-Boy Incorporated:企業の戦略・SWOT・財務情報
    La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report Summary La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NetApp Inc:企業の戦略・SWOT・財務情報
    NetApp Inc - Strategy, SWOT and Corporate Finance Report Summary NetApp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Piramal Enterprises Ltd (PEL):製薬・医療:M&Aディール及び事業提携情報
    Summary Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. I …
  • BioGaia AB (BIOG B):製薬・医療:M&Aディール及び事業提携情報
    Summary BioGaia AB (BioGaia) is a biopharmaceutical company, which develops, markets and sells probiotic products. The company sells its probiotic food supplements and oral health products in various dosage forms including drops, lozenges, tablets, chewable tablets, oral rehydration salts (ORS), str …
  • Fujirebio Europe NV:企業の戦略的SWOT分析
    Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆